Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul 120-752, Korea.
Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul 120-752, Korea.
Int J Mol Sci. 2018 Sep 21;19(10):2867. doi: 10.3390/ijms19102867.
Locally advanced thyroid cancer exhibits aggressive clinical features requiring extensive neck dissection. Therefore, it is important to identify changes in the tumor biology before local progression. Here, whole exome sequencing (WES) using tissues from locally advanced papillary thyroid cancer (PTC) presented a large number of single nucleotide variants (SNVs) in the metastatic lymph node (MLN), but not in normal tissues and primary tumors. Among those MLN-specific SNVs, a novel HHIP G516R (G1546A) mutation was also observed. Interestingly, in-depth analysis for exome sequencing data from the primary tumor presented altered nucleotide 'A' at a very low frequency indicating intra-tumor heterogeneity between the primary tumor and MLN. Computational prediction models such as PROVEAN and Polyphen suggested that HHIP G516R might affect protein function and stability. In vitro, HHIP G516R increased cell proliferation and promoted cell migration in thyroid cancer cells. HHIP G516R, a missense mutation, could be a representative example for the intra-tumor heterogeneity of locally advanced thyroid cancer, which can be a potential future therapeutic target for this disease.
局部晚期甲状腺癌表现出侵袭性的临床特征,需要广泛的颈部清扫。因此,在局部进展之前识别肿瘤生物学的变化非常重要。在这里,使用局部晚期甲状腺乳头状癌(PTC)的组织进行全外显子组测序(WES),在转移性淋巴结(MLN)中发现了大量的单核苷酸变异(SNVs),但在正常组织和原发肿瘤中没有。在这些 MLN 特异性 SNVs 中,还观察到了一个新的 HHIP G516R(G1546A)突变。有趣的是,对原发肿瘤的外显子组测序数据进行深入分析显示,在非常低的频率下存在改变的核苷酸“A”,表明原发肿瘤和 MLN 之间存在肿瘤内异质性。PROVEAN 和 Polyphen 等计算预测模型表明,HHIP G516R 可能影响蛋白质功能和稳定性。在体外,HHIP G516R 增加了甲状腺癌细胞的增殖并促进了细胞迁移。HHIP G516R 是一种错义突变,可能是局部晚期甲状腺癌肿瘤内异质性的代表性例子,它可能是这种疾病的一个潜在的未来治疗靶点。